224
Views
6
CrossRef citations to date
0
Altmetric
Articles

Do repeated transurethral procedures under general anesthesia influence mortality in patients with non-invasive urothelial bladder cancer? A Danish national cohort study

, , , , &
Pages 281-289 | Received 24 Jan 2020, Accepted 09 Jun 2020, Published online: 25 Jun 2020

References

  • Erikson MS, Petersen AC, Andersen KK, et al. National incidence and survival of patients with non-invasive papillary urothelial carcinoma: a Danish population study. Scand J Urol. 2018;52(5–6):364–370.
  • Linton KD, Rosario DJ, Thomas F, et al. Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance. J Urol. 2013;189(3):828–833.
  • Rieken M, Xylinas E, Kluth L, et al. Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder. Eur Urol. 2014;65(1):201–209.
  • Liedberg F, Hagberg O, Holmang S, et al. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study. Scand J Urol. 2015; 201549(4):290–295.
  • Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49(3):466–465.
  • Pereira JF, Pareek G, Mueller-Leonhard C, et al. The perioperative morbidity of transurethral resection of bladder tumor: implications for quality improvement. Urology. 2019;125:131–137.
  • Patel HD, Ball MW, Cohen JE, et al. Morbidity of urologic surgical procedures: an analysis of rates, risk factors, and outcomes. Urology. 2015;85(3):552–559.
  • Matulewicz RS, Sharma V, McGuire BB, et al. The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: an analysis of ACS NSQIP data. Urol Oncol. 2015;33(8):338 e19.
  • De Nunzio C, Franco G, Cindolo L, et al. Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol. 2014;40(1):90–95.
  • Hollenbeck BK, Miller DC, Taub D, et al. Risk factors for adverse outcomes after transurethral resection of bladder tumors. Cancer. 2006;106(7):1527–1535.
  • Turrentine FE, Wang H, Simpson VB, et al. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203(6):865–877.
  • Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549.
  • Erichsen R, Lash TL, Hamilton-Dutoit SJ, et al. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol. 2010;2:51–56.
  • The Danish Pathology Data Bank – Snomed (in Danish: Patobanken – Snomed) www.patobank.dk/snomed/: The Danish Health Data Authority and the Danish Pathology Data Bank representatives; [cited 2020 Jun 15]. Available from: www.patobank.dk.
  • College of American Pathologists: SNOMED: Systematized nomenclature of medicine. 2nd ed. Chicago Illinois. 1979; [cited 2020 Jun 15]. Availbale from: http://www.cap.org/.
  • Brierly JD, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. Oxford: Wiley Blackwell; 2016. p. 204–208.
  • Moch H, Humphrey PA, Ulbright TM, et al. WHO classification of tumours of the urinary system and male genital organs. 4th ed. Lyon: IARC; 2016.
  • Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
  • Statistics Denmark www.statbank.dk; [cited 2020 Jun 15]. Available from: www.statbank.dk.
  • R Core Team. R: A language and environment for statistical computing. R Foundation for statistical computing. Vienna, Austria. 2016; [cited 2020 Jun 15]. Available from: https://www.r-project.org/
  • Mogensen K, Christensen KB, Vrang ML, et al. Hospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumour. Scand J Urol. 2016;50(3):170–174.
  • Hermann GG, Mogensen K, Rosthoj S. Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis. Scand J Urol. 2018;52(3):194–198.
  • Hermann GG, Mogensen K, Toft BG, et al. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies. Scand J Urol Nephrol. 2012;46(1):31–36.
  • Cambier S, Sylvester RJ, Collette L, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 Urothelial bladder cancer patients treated with 1–3 Years of maintenance bacillus calmette-guérin. Eur Urol. 2016; 69(1):60–69.
  • Hermann GG, Mogensen K, Carlsson S, et al. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. BJU Int. 2011;108(8 Pt 2):E297–303.
  • Malmstrom PU, Agrawal S, Blackberg M, et al. Non-muscle-invasive bladder cancer: a vision for the future. Scand J Urol. 2017;51(2):87–94.
  • Burger M, Grossman HB, Droller M, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013;64(5):846–854.
  • Sorenby A, Baseckas G, Bendahl PO, et al. Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients. Scand J Urol. 2019;53(2–3):109–115.
  • Schroeck FR, Lynch KE, Li Z, et al. The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer. Cancer. 2019;125(18):3147–3154.
  • Placzek F, Cordero E, Kretschmer SM, et al. Morpho-molecular ex vivo detection and grading of non-muscle-invasive bladder cancer using forward imaging probe based multimodal optical coherence tomography and Raman spectroscopy. Analyst. 2020;145(4):1445–1456.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.